KIZEFMA
Live / Allowed — Published for opposition (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79437264
- Mark type
- Stylized text
- Filed
- 16 Oct 2025
- Published for opposition
- 31 Mar 2026
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; immunomodulatory pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases.
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTICE OF PUBLICATION
- 05 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2026 — ASSIGNED TO EXAMINER
- 24 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB